LifeSci Capital Downgrades Verve Therapeutics (VERV) to Market Perform
Tweet Send to a Friend
LifeSci Capital analyst Cory Jubinville downgraded Verve Therapeutics (NASDAQ: VERV) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
